Compositions and methods for in utero delivery
US12268774B2 · kind B2 · utility
0Cited by
92References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 27, 2023 |
| Grant date | Apr 8, 2025 |
| Priority date | — |
| Expiry date | Feb 18, 2044 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P21/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for fetal or in utero delivery of active agents are provided. The compositions are most typically administered intravenously via the vitelline vein, umbilical vein, or directly into the amniotic cavity of a pregnant mother. Fibroblast growth factor is to correct structural defects of neural tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.